Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.
By J. Haller, F. Bandello, R. Belfort, M. Blumenkranz, M. Gillies, J. Heier, A. Loewenstein, Y. Yoon, Marie-Louise Jacques, J. Jiao and 2 more. Ophthalmology (Rochester, Minn.), 2010
1,068 citations recorded by the source corpus.
Subfields: Ophthalmology, Radiology, Nuclear Medicine and Imaging
View Paper: https://www.semanticscholar.org/paper/1591482db17ed21f2c997cb5b6623f24e0a55bc7
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Ophthalmology
In Radiology, Nuclear Medicine and Imaging
Citations in the corpus
- Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. (2014, methodology): “In the sham procedure, a needleless applicator was pressed against the conjunctiva of the study eye.(25)”